By Daniella Parra Portillo’s Inc. (NASDAQ: PTLO) said revenue increased 12.3% to $169.2 million in the second quarter and the company expects to open eight to nine locations by the end of the year. Portillo’s delivered another quarter of double-digit...

By Daniella Parra Potbelly Corporation (NASDAQ: PBPB), the iconic neighborhood sandwich shop concept, said revenue increased 9.2% to $126.6 million in the second quarter. Company shop sales increased by 8.4% to $124.7 million compared to $115.0 million, with Average Unit Volumes...

By Daniella Parra ProSomnus, Inc. (NASDAQ: OSA), said second quarter revenue rose 43% to a record $6.9 million, and $12.7 million in the first half of 2023. Gross margins remained at 54% for the quarter, the company said in a...

By Daniella Parra Planet Fitness, Inc. (NYSE: PLNT) said second quarter total revenue increased 27.6% to $286.5 million as the chain opened 26 new stores. Adjusted EBITDA increased $29.8 million to $118.9 million from $89.1 million in the prior year period, it said in a statement....

By Daniella Parra Solo Brands, Inc. (NYSE: DTC) said second quarter wholesale revenue increased 57% to $31.3 million. Net sales reached $130.9 million driven by strong wholesale demand and adjusted EBITDA was $25 million, up 5.6% since the same period...

By Daniella Parra Comera Life Sciences Holdings, Inc. (Nasdaq: CMRA) said it completed a $4.1 million private placement of shares and warrants to existing stockholders. The company said it aims to develop new biologic medicines to improve patient access and...

  By Daniella Parra First Watch Restaurant Group, Inc. (NASDAQ: FWRG) said revenue increased 17.3% to $216.3 million in the second quarter. The chain opened nine new system-wide restaurants, including six company-owned locations in the quarter, it said in a...

By Daniella Parra Vaxxinity, Inc. (Nasdaq: VAXX) said it appointed Peter Powchik, M.D. as Executive Vice President, Global Scientific Director overseeing its scientific direction and lead development efforts. Powchik was previously Senior Vice President at Regeneron Pharmaceuticals, the company said....

By Daniella Parra Plus Therapeutics (Nasdaq: PSTV) said it appointed Dr. Pius Maliakal as VP of Clinical Operations. With over 20 years of global oncology experience, he will lead key clinical initiatives, advancing the ReSPECT-GBM and ReSPECT-LM trials for central...

By Daniella Parra Octave Bioscience said it secured a $30 million extension to its Series B funding round. The investment, led by Novartis, Hikma Ventures and Intermountain Ventures, will accelerate commercialization of their precision care solution for multiple sclerosis (MS)...